CCM
MBIO icon

Consonance Capital Management’s Mustang Bio MBIO Stock Holding History

Consonance Capital Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,213
Closed -$10.3M – 40
2019
Q3 		$10.3M Sell
4,213
-287
-6% -$785K 1.02% 24
2019
Q2 		$12.4M Buy
+4,500
New +$12.8M 0.88% 24

Other funds holding MBIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Consonance Capital Management's MBIO Position: Q4 2019 in Review

Consonance Capital Management sold out of Mustang Bio (MBIO) in Q4 2019, closing a stake of 4,213 shares — an estimated $10.3M sold.

Consonance Capital Management first reported a position in MBIO in Q2 2019 and held it in 2 quarters. The position peaked at $12.4M in Q2 2019. 55 funds tracked by Wall St. Rank hold MBIO as of Q4 2019.

  • Consonance Capital Management reported no remaining Mustang Bio position as of Q4 2019 after selling out during the quarter.
  • Consonance Capital Management sold 4,213 Mustang Bio shares in Q4 2019, an estimated $10.3M.
  • Consonance Capital Management first reported a position in Mustang Bio in Q2 2019 and held it in 2 quarters.
  • Consonance Capital Management's Mustang Bio position peaked at $12.4M in Q2 2019.
  • 55 funds tracked by Wall St. Rank held Mustang Bio as of Q4 2019.

Based on Consonance Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.